Abstract
The luteinizing hormone/chorionic gonadotropin receptor (LHCGR) belongs to the family of G-protein coupled receptors and binds both luteinizing hormone (LH) and human chorionic gonadotropin (hCG). Ligand-receptor interaction mediates a downstream cascade of events which is essential for ovulation in women, and expression of the male phenotype in men. The human LHCGR gene consists of 11exons and 10 introns. Homozygous and compound heterozygous mutations may inactivate the receptor by altering its structure and subsequent function. Herein we reported a novel, compound heterozgygous inactivating LHCGR mutation in a woman who presented with secondary infertility, having previously carried to term a donor oocyte pregnancy. A 27 bp deletion was detected in exon I at amino acid number 12. This mutation involved the signal peptide region, which is important for protein targeting, maturation and cellular expression. Another mutation involving a 2 base pair (thymine and cytosine) deletion was detected in exon 11 at amino acid number 586. This deletion produced a frameshift resulting in a premature stop codon and a truncated protein. An XY sibling with the same mutations was phenotypically female and misdiagnosed as complete androgen insensitivity syndrome. Other unaffected family members were genetically tested and carried one of the two mutations.
Similar content being viewed by others
References
McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev. 2000;21:200–14.
Hsieh M, Lee D, Panigone S, et al. Luteinizing hormone-dependent activation of the epidermal growth factor network is essential for ovulation. Mol Cell Biol. 2007;27:1914–24.
Otsuka F, McTavish KJ, Shimasaki S. Integral role of GDF-9 and BMP-15 in ovarian function. Mol Reprod Dev. 2011;78:9–21.
Ascoli M, Fanelli F, Segaloff DL. The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr Rev. 2002;23:141–74.
Arnhold IJ, Lofrano-Porto A, Latronico AC. Inactivating mutations of luteinizing hormone beta-subunit or luteinizing hormone receptor cause oligo-amenorrhea and infertility in women. Horm Res. 2009;71:75–82.
Qiao J, Han B, Liu BL, et al. A splice site mutation combined with a novel missense mutation of LHCGR cause male pseudohermaphroditism. Hum Mutat. 2009;30:E855–65.
Latronico AC, Chai Y, Arnhold IJ, Liu X, Mendonca BB, Segaloff DL. A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor. Mol Endocrinol. 1998;12:442–50.
Troppmann B, Kleinau G, Krause G, Gromoll J. Structural and functional plasticity of the luteinizing hormone/choriogonadotrophin receptor. Hum Reprod Update. 2013;19:583–602.
Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev. 2000;21:90–113.
Puett D, Li Y, Angelova K, et al. Structure-function relationships of the luteinizing hormone receptor. Ann N Y Acad Sci. 2005;1061:41–54.
Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev. 1996;17:121–55.
Ben-Ami I, Komsky A, Bern O, Kasterstein E, Komarovsky D, Ron-El R. In vitro maturation of human germinal vesicle-stage oocytes: role of epidermal growth factor-like growth factors in the culture medium. Hum Reprod. 2011;26:76–81.
Peluffo MC, Ting AY, Zamah AM, et al. Amphiregulin promotes the maturation of oocytes isolated from the small antral follicles of the rhesus macaque. Hum Reprod. 2012;27:2430–7.
Park JY, Su YQ, Ariga M, Law E, Jin SL, Conti M. EGF-like growth factors as mediators of LH action in the ovulatory follicle. Science. 2004;303:682–4.
Rutkowski DT, Ott CM, Polansky JR, Lingappa VR. Signal sequences initiate the pathway of maturation in the endoplasmic reticulum lumen. J Biol Chem. 2003;278:30365–72.
Wu SM, Hallermeier KM, Laue L, et al. Inactivation of the luteinizing hormone/chorionic gonadotropin receptor by an insertional mutation in Leydig cell hypoplasia. Mol Endocrinol. 1998;12:1651–60.
Hong S, Phang T, Ji I, Ji TH. The amino-terminal region of the luteinizing hormone/choriogonadotropin receptor contacts both subunits of human choriogonadotropin: I. MUTATIONAL ANALYSIS. J Biol Chem. 1998;273:13835–40.
Song Y, Yi C, Lee C, et al. Interaction and activation of luteinzing hormone receptor. Indian J Exp Biol. 2002;40:424–33.
Dufau ML, Liao M, Zhang Y. Participation of signaling pathways in the derepression of luteinizing hormone receptor transcription. Mol Cell Endocrinol. 2010;314:221–7.
Lebon G, Warne T, Tate CG. Agonist-bound structures of G protein-coupled receptors. Curr Opin Struct Biol. 2012;22:482–90.
Kosugi S, Mori T, Shenker A. The role of Asp578 in maintaining the inactive conformation of the human lutropin/choriogonadotropin receptor. J Biol Chem. 1996;271:31813–7.
Richter-Unruh A, Martens JW, Verhoef-Post M, et al. Leydig cell hypoplasia: cases with new mutations, new polymorphisms and cases without mutations in the luteinizing hormone receptor gene. Clin Endocrinol (Oxf). 2002;56:103–12.
Richter-Unruh A, Korsch E, Hiort O, Holterhus PM, Themmen AP, Wudy SA. Novel insertion frameshift mutation of the LH receptor gene: problematic clinical distinction of Leydig cell hypoplasia from enzyme defects primarily affecting testosterone biosynthesis. Eur J Endocrinol. 2005;152:255–9.
Segaloff DL. Diseases associated with mutations of the human lutropin receptor. Prog Mol Biol Transl Sci. 2009;89:97–114.
Martens JW, Verhoef-Post M, Abelin N, et al. A homozygous mutation in the luteinizing hormone receptor causes partial Leydig cell hypoplasia: correlation between receptor activity and phenotype. Mol Endocrinol. 1998;12:775–84.
Laue LL, Wu SM, Kudo M, et al. Compound heterozygous mutations of the luteinizing hormone receptor gene in Leydig cell hypoplasia. Mol Endocrinol. 1996;10:987–97.
Ryu K, Lee H, Kim S, et al. Modulation of high affinity hormone binding. Human choriogonadotropin binding to the exodomain of the receptor is influenced by exoloop 2 of the receptor. J Biol Chem. 1998;273:6285–91.
Ji I, Lee C, Song Y, Conn PM, Ji TH. Cis- and trans-activation of hormone receptors: the LH receptor. Mol Endocrinol. 2002;16:1299–308.
Kossack N, Simoni M, Richter-Unruh A, Themmen AP, Gromoll J. Mutations in a novel, cryptic exon of the luteinizing hormone/chorionic gonadotropin receptor gene cause male pseudohermaphroditism. PLoS Med. 2008;5:e88.
Menon KM, Menon B. Structure function and regulation of gonadotropin receptors - a perspective. Mol Cell Endocrinol. 2012;356:88–97.
Piersma D, Verhoef-Post M, Look MP, et al. Polymorphic variations in exon 10 of the luteinizing hormone receptor: functional consequences and associations with breast cancer. Mol Cell Endocrinol. 2007;276:63–70.
Atger M, Misrahi M, Sar S, Le Flem L, Dessen P, Milgrom E. Structure of the human luteinizing hormone-choriogonadotropin receptor gene: unusual promoter and 5′ non-coding regions. Mol Cell Endocrinol. 1995;111:113–23.
Reshef E, Lei ZM, Rao CV, Pridham DD, Chegini N, Luborsky JL. The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua. J Clin Endocrinol Metab. 1990;70:421–30.
Shemesh M. Actions of gonadotrophins on the uterus. Reproduction. 2001;121:835–42.
Zhang M, Shi H, Segaloff D, Van Voorhis BJ. Expression and localization of luteinizing hormone receptor in the female mouse. Biol Reprod. 2001;64:179–87.
Gridelet V, Tsampalas M, Berndt S, et al. Evidence for cross-talk between the LH receptor and LH during implantation in mice. Reprod Fertil Dev. 2013;25:511–22.
Mishra S, Lei ZM, Rao CV. A novel role of luteinizing hormone in the embryo development in cocultures. Biol Reprod. 2003;68:1455–62.
Lin DX, Lei ZM, Li X, Rao CV. Targeted disruption of LH receptor gene revealed the importance of uterine LH signaling. Mol Cell Endocrinol. 2005;234:105–16.
Rao CV, Lei ZM. Consequences of targeted inactivation of LH receptors. Mol Cell Endocrinol. 2002;187:57–67.
Pakarainen T, Zhang FP, Poutanen M, Huhtaniemi I. Fertility in luteinizing hormone receptor-knockout mice after wild-type ovary transplantation demonstrates redundancy of extragonadal luteinizing hormone action. J Clin Invest. 2005;115:1862–8.
Author information
Authors and Affiliations
Corresponding author
Additional information
Capsule A novel compound heterozygous mutation involving exon 1 and 10 resulting in LH/hCG resistance, infertility and female phenotype in XY and XX siblings.
Rights and permissions
About this article
Cite this article
Mitri, F., Bentov, Y., Behan, L.A. et al. A novel compound heterozygous mutation of the luteinizing hormone receptor –implications for fertility. J Assist Reprod Genet 31, 787–794 (2014). https://doi.org/10.1007/s10815-014-0249-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-014-0249-5